Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors.
Wu W, Dong Y, Gao J, Gong M, Zhang X, Kong W, Li Y, Zeng Y, Si D, Wei Z, Ci X, Jiang L, Li W, Li Q, Yi X, Liu C.
Wu W, et al.
Cancer Sci. 2015 Jun;106(6):747-756. doi: 10.1111/cas.12672. Epub 2015 May 26.
Cancer Sci. 2015.
PMID: 25867020
Free PMC article.